Related Experiment Videos
Preventing chronicity of migraine
Marcello Fanciullacci1, Francesco De Cesaris
1Headache Center, Department of Internal Medicine, University of Florence, Viale Pieraccini 18, I-50139, Firenze, Italy. fanciullac.marcello@tiscalinet.it
The Journal of Headache and Pain
|December 20, 2005
Summary
Early triptan therapy and recognizing neurological changes can prevent chronic migraine progression. Managing attack frequency and avoiding medication overuse are key to preventing transformed migraine.
Area of Science:
- Neurology
- Pain Medicine
Background:
- Chronic migraine and transformed migraine represent a disabling progression from episodic headaches.
- Cutaneous allodynia during attacks indicates central nervous system sensitization in the trigeminovascular system.
Purpose of the Study:
- To explore early therapeutic interventions and indicators for preventing migraine chronification.
- To identify key predictors and risk factors for migraine progression.
Main Methods:
- Review of existing literature on migraine pathophysiology and treatment.
- Analysis of factors influencing the transition from episodic to chronic migraine.
Main Results:
- Early triptan therapy may prevent central sensitization and migraine chronification.
- Non-headache neurological changes between attacks signal headache transformation.
- High attack frequency is a significant predictor of migraine progression.
- Medication overuse, female sex, obesity, and stressful life events are major risk factors.
Conclusions:
- Timely intervention with triptans and vigilant monitoring for neurological changes are crucial.
- Prophylactic treatments should target patients with frequent attacks.
- Preventing medication overuse is paramount to avoid accelerating disease progression.